CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union
CSL Delivers World's First Battery-Powered Self-Unloading Bulk Carrier to Support Adbri Operations
Australia says CSL unit Seqirus to discontinue Benpen injections from November
CSL Limited (CSLLY) Shareholder/Analyst Call Transcript
CSL: The Plasma Moat Is Being Rebuilt While The Market Prices The Noise
Should Value Investors Buy CSL Limited (CSLLY) Stock?
CSLLY vs. ACAD: Which Stock Is the Better Value Option?
Carlisle Companies: Resilient In Challenging Sector Backdrop
CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?
CSLLY or ARGX: Which Is the Better Value Stock Right Now?
CSLLY vs. ARGX: Which Stock Is the Better Value Option?
Analyzing CSL (OTCMKTS:CSLLY) and Ascentage Pharma Group International (NASDAQ:AAPG)
CSL announces expansion of Illinois plasma therapy manufacturing facility
CSLLY or EXAS: Which Is the Better Value Stock Right Now?
CSL signs licensing deal with Eli Lilly for clazakizumab to treat kidney disease
CSLLY vs. EXAS: Which Stock Is the Better Value Option?
CSL Limited (CSLLY) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
CSL Limited (CSLLY) Q2 2026 Earnings Call Transcript
CSL Limited (CSLLY) Discusses Leadership Transition and Appointment of Interim CEO Transcript
CSLLY or TECH: Which Is the Better Value Stock Right Now?
CSL Limited: Upside Potential Is Strong From These Levels But I Remain Cautious
Deutsche Bank Appointed as Successor Depositary Bank for the American Depositary Receipt Program of CSL Limited
Carlisle Companies: Residential Construction-Driven Momentum
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years
Carlisle: Mixed Q3, Undervalued Ahead Of Policy Easing
CSL Limited (CSLLY) Analyst/Investor Day Prepared Remarks Transcript
Carlisle Companies Incorporated (NYSE:CSL) Given Consensus Rating of “Hold” by Brokerages
Asset Management One Co. Ltd. Sells 673 Shares of Carlisle Companies Incorporated $CSL
CSL Limited (CSLLY) Shareholder/Analyst Call Transcript
CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE)
Recent RWE Data Show Cell-Based Influenza Vaccines Offer 20% Greater Protection in the Prevention of Test-Confirmed Influenza in Pediatric and Adult Populations Relative to Standard Egg-Based Influenza Vaccines
My Top 5 Biotech Stocks Big Pharma Could Buy Next
UCLOUDLINK's Groundbreaking PetPhone Launches on HKT's CSL Network in Hong Kong
CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy
CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy
CSL Limited (CSLLY) Q4 2025 Earnings Call Transcript
Australian biopharma firm CSL posts 14% rise in annual profit
Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb
President Trump demands drugmakers slash prices within 60 days
ALKS or CSLLY: Which Is the Better Value Stock Right Now?
Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus
U.S. Food and Drug Administration Approves CSL's ANDEMBRY® (garadacimab-gxii), the Only Prophylactic Hereditary Angioedema (HAE) Treatment Targeting Factor XIIa with Once-Monthly Dosing for All Patients From the Start
KMDA vs. CSLLY: Which Stock Should Value Investors Buy Now?
England's NICE recommends FILSPARI® (sparsentan) as a treatment option for IgA nephropathy
Travere Therapeutics and CSL Vifor Announce Standard EU Approval of FILSPARI® (sparsentan) for IgA Nephropathy
CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy